The World Health Organization (WHO) recently declared the 2019 novel coronavirus (nCov) as a global emergency after it killed nearly 300 people in China and affected various cities in Asia, Australia, North America, Europe, and the Middle East.
The virus originated in Wuhan, China, but the rest of the world isn’t safe. China and other heavily impacted countries are working tirelessly to contain and put a stop to the virus. Japan, specifically, has detected 17 cases at the time of writing and immediately responded. As a result, Japan’s National Institute of Infectious Diseases (NIID) announced that it succeeded in cultivating and isolating nCov from a person in Japan who has been confirmed to have the virus..
Researchers from Japan’s NIID are now analyzing the isolated nCov virus captured from confined patients to come up with vaccines and medicines that can combat it. But the main priority is to create a test kit that can provide a quick diagnosis for suspected cases in all countries affected.
The isolated virus’ gene sequences 99.9% matched the sequence released by the Chinese government. Although it won’t lead to infectiousness or toxicity, any successful findings and antidote from NIID’s labs might 100% work on the actual virus.
Since nCov is a global emergency, NIID will lend the isolated virus to researchers and medical institutes around the world to help them discover more unknown facts about the virus and its toxicity.